1. Indonesia Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
PT Sejahteraraya Anugrahjaya Tbk

PT Sejahteraraya Anugrahjaya Tbk

IIDX:SRAJ
11,000.00
IDR
+50.00
(+0.46%)
-32.04EPS
134.63TMarket Cap
PT Sejahteraraya Anugrahjaya Tbk
IDX:SRAJ
(Indonesia Stock Exchange)

Recent

price

11,000.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
IDR
21.17
25.53
33.94
33.81
40.96
54.02
52.77
57.86
67.17
83.5
106.98
160.36
161.18
208.6
195.03
212.21
196.49
Revenue per Share
0.85
0.71
0.83
-8.42
-12.07
-15.9
-8.9
-9.24
-7.95
-6.31
-1.2
13.77
-3.69
-3.21
-1.96
-16.31
-32.05
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
78.96
92.17
113.63
149
137.46
121.87
157.77
148.72
153.47
147.97
146.15
160.52
157.82
154.66
152.51
108.88
89
Book Value per Share
78.87
92.08
113.11
148.3
136.92
121.53
157.67
148.66
133.62
127.67
125.11
139.2
136.94
133.87
131.73
87.28
67.55
Tangible Book Value per Share
7,047
6,560
5,730
6,550
8,313
8,313
10,918
10,918
12,001
12,001
12,001
12,001
12,000
12,000
12,000
12,202
12,239
Basic Weighted Avg Shares
149,178
167,481
194,502
221,474
340,517
449,071
576,182
631,680
806,031
1,002,002
1,283,799
1,924,453
1,934,164
2,503,174
2,340,431
2,589,440
2,404,842
Sales/Revenue/Turnover
5.57
13.09
10.22
-18.72
-28.54
-21.8
-14.85
-13.97
-9.89
-4.51
1.52
12
1.83
4.36
7.48
3.47
-0.75
Operating Margin (%)
- -
24,354
28,369
7,915
16,210
16,015
16,141
15,235
16,240
17,364
30,159
51,760
66,127
76,955
82,535
100,593
103,490
Depreciation Expense
6,005
4,639
4,737
-55,121
-100,333
-132,172
-97,222
-100,850
-95,419
-75,670
-14,381
165,308
-44,315
-38,490
-23,513
-199,000
-392,217
Net Income, GAAP
27.75
21.02
25.09
- -
- -
- -
- -
- -
- -
- -
7,675.12
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
4.03
2.77
2.44
-24.89
-29.46
-29.43
-16.87
-15.97
-11.84
-7.55
-1.12
8.59
-2.29
-1.54
-1
-7.69
-16.31
Profit Margin (%)
-19,129
-11,989
-186,863
37,095
69,859
-139,915
542,233
178,428
-226,133
-669,879
-707,973
-1,637,726
-1,157,152
-1,107,277
-1,764,244
917,887
622,437
Working Capital
116,633
167,069
326,107
371,761
292,777
169,597
75,290
173
60,000
163,421
829,686
203,174
1,164,892
1,542,298
1,125,485
4,522,514
4,800,704
LT Debt
556,738
649,356
654,081
1,245,825
1,144,969
1,015,009
1,724,050
1,624,877
1,842,720
1,776,625
1,754,736
1,927,403
1,895,138
1,857,457
1,833,304
1,335,725
1,091,118
Total Equity
0.91
2.27
1.47
- -
- -
- -
- -
- -
- -
- -
-49.73
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
0.92
2.37
1.44
- -
- -
- -
- -
- -
- -
- -
-220.77
- -
- -
- -
- -
- -
- -
Return on Capital (%)
1.15
0.77
0.73
-5.82
-8.41
-12.26
-7.11
-6.03
-5.51
-4.18
-0.81
8.98
-2.32
-2.05
-1.28
-12.58
-30.2
Return on Common Equity (%)

Capital Structure

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
169,578
160,026
158,035
LT Borrowings
4,517,089
4,577,134
4,796,068
LT Finance Leases
5,425
4,567
4,636
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12,239
12,239
12,239
Market Capitalization
201,942,840
183,890,374
134,628,560

Working Capital

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,527,917
2,246,114
2,186,356
Cash, Cash Equivalents & STI
1,826,263
1,589,719
1,530,185
Accounts Receivable, Net
557,933
494,861
502,353
Inventories
73,323
66,622
67,583
Total Current Liabilities
1,610,030
1,544,259
1,563,919
Payables & Accruals
- -
- -
- -
ST Debt
169,578
160,026
158,035
Deferred Revenue
- -
- -
- -

Growth Rates

IDR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.04%
-4.45%
-27.14%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
-81.18%
-136.41%
746.34%
Sales/Revenue/Turnover
20.19%
16.79%
10.64%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
746,135
768,287
817,003
816,920
2,340,431
2025
590,384
388,443
- -
714,372
2,589,440
2026
644,900
657,127
- -
- -
- -

Quarterly Earnings Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.4
0.41
-0.12
-2.65
-1.96
2025
-2.33
-3.02
- -
-9.03
-16.31
2026
-7.4
-12.59
- -
- -
- -

Quarterly Dividends Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
PT Sejahteraraya Anugrahjaya Tbk delivers comprehensive healthcare services across Indonesia. The enterprise focuses on operating a network of modern hospitals, distinguished by the Mayapada Hospital brand, which offer a wide array of specialized medical treatments. These facilities encompass both extensive inpatient and outpatient care, supported by various centers of excellence including neuroscience, cardiovascular, oncology, and orthopedic specialties. Established in 1991 and headquartered in Tangerang, Indonesia, the company has expanded its presence to seven major cities, targeting the middle-to-upper market segment with high-quality medical provisions. Notable developments include a significant investment from Bain Capital in December 2024 to further scale its operations and an ongoing expansion plan to increase its hospital count to nine by 2027, enhancing bed capacity and introducing new facilities in strategic locations. Mayapada Hospital South Jakarta received international accreditation from the Joint Commission International in 2023. PT Sejahteraraya Anugrahjaya Tbk functions as a subsidiary of PT Surya Cipta Inti Cemerlang.